Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1995-03-22
1998-10-13
Knode, Marian C.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
4241861, 4241841, 435 643, 435 691, 4352351, 4352542, 530350, 530412, 530 2372, A61K 3902, A61K 3900, C12P 2106, C07K 100
Patent
active
058208704
ABSTRACT:
The present invention is directed to vaccines for human papillomavirus type 18 and derivatives thereof.
REFERENCES:
patent: 5437951 (1995-08-01), Lowy et al.
Cole, et al., "Nucleotide Sequence and Comparative Analysis of the Human Papillomavirus Type 18 Genome", J. Mol. Biol., 193 (4), pp. 599-608 (1987).
Brown, et al., "Analysis of the L1 Gene Product of Human Papillomavirus Type 16 by Expression in a Vaccinia Virus Recombinant" J. Gen. Virol. (1988) vol. 69, pp. 1263-1273.
Doorbar, et al., "Identification of Proteins Encoded by the L1 and L2 Open Reading Frames of Human Papillomavirus 1a", J. of Virol., Sep. 1987, vol. 67, No. 9., pp. 2793-2799.
Hanenese, et al., "Self-Assembly of Human Papillomavirus Type 1 Capsids by Expression of the L2 Protein Alone or by Coexpression . . . ", J. of Virol., Jan. 1993, vol. 67, No. 1, pp. 315-322.
Kirnbauer, R., "Papillomavirus L1 Major Capsid Protein Self-assembles into Virus-like Particles that are Highly Immunogenic", Proc Natl. Acad. Sci., vol. 89, pp. 12180-12184, Dec. 1992.
LeCann, et al., "Self-Assembly of Human Papillomavirus Type 16 Capsids by Expression of the L1 Protein in Insect Cells", FEMS Microb. Lett., 117 (1994), pp. 269-274.
Lin, et al., "Effective Vaccination Against Papilloma Development by Immunication with L1 or L2 Structural Protein . . . ", Virology, vol. 187, (1992) pp. 612-619.
Rose, et al., "Expression of Human Papillomavirus Type 11 L1 Protein in Insect Cells: In Vivo and In Vitro Assembly of Viruslike Particles", J. of Virol., Apr. 1993, pp. 1936-1944.
Steele, et al., "Humoral Assays of Human Sera to Disrupted and Nondisrupted Epitopes of Human Papillomavirus Type 1", Virology, vol. 174, (1990) pp. 388-398.
Strike, et al., "Expression in Escherichia Coli of Seven DNA Fragments Comprising the Complete L1 and L2 Open . . . ", J. Gen. Virol. (1989) vol. 70, pp. 543-555.
Zhou, et al., "Synthesis and Assembly of Infectious Bovine Papillomavirus Particles In Bitro", J. Gen. Virol., (1993), Fol. 74, pp. 763-768.
Zhou, et al., "Expression of Vaccinia Recombinant HPV HPV 16 L1 and L2 ORF Proteins in Eipthelial Cells . . . ", Virology, vol. 185, (1991), pp. 251-257.
Zhou, et al., "Increased Antibody Responses to Human Papillopomavirus Type 16 L1 Protein Expressed by Recombinant Vaccinia . . . ", J. Gen. Virology, (1990), vol. 71, pp. 2185-2190.
Sasagawa, et al., "Synthesis and Assembly of Virus-like Particles of Human Papillomaviruses Type 6 . . . ", Virology, 206, pp. 126-135 (1995).
Krinbauer et al, 1993, J. Virol., vol. 67, No. 12 pp. 6929-6936.
George Hugh A.
Hofman Kathryn J.
Jansen Kathrin U.
Joyce Joseph G.
Neeper Michael P.
Giesser Joanne M.
Knode Marian C.
Merck & Co. , Inc.
Salimi Ali R.
Tribble Jack L.
LandOfFree
Recombinant human papillomavirus type 18 vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant human papillomavirus type 18 vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant human papillomavirus type 18 vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-310929